Kidney function in the elderly: The payment of time;Función renal en el anciano: el pago del tiempo

Hipertension y Riesgo Vascular

Volumn 26, Issue 1, 2009, Pages 2-6

  Fernandez Vega F ^a   Marin Iranzo R ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ATHEROSCLEROSIS; BLOOD VESSEL COMPLIANCE; CARDIOVASCULAR RISK; EDITORIAL; FLUID BALANCE; GLOMERULUS; HEART MUSCLE; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TUBULE; LIFESTYLE; PREVALENCE; RISK ASSESSMENT; RISK FACTOR;

EID: 70350436095     PISSN: 18891837     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1889-1837(09)70506-9     Document Type: Editorial

References (42)

1. Mancia G., De Backer G., Dominiczak A., Cifkova R., Fagard R., Germano G., et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of European Society of Cardiology (ESC). J Hypertens 25 (2007) 1105-1187
2. National Institute on Aging [citado 17 Nov 2008]. Disponible en: http://www.nia.nih.gov
3. Sociedad Española de Geriatría [citado 17 Nov 2008]. Disponible en: http://www.seg.es
4. Naciones Unidas [citado 17 Nov 2008]. Disponible en: http://www.un.org
5. Instituto Nacional de Estadística [citado 17 Nov 2008]. Disponible en: http://www.ine.es
6. Shlipak MG, Katz R, Kestenbaum B, Fried L, Siscovick D, Sarnak MJ. Clinical and subclinical cardiovascular disease and kidney function decline in the elderly. Atherosclerosis. 2008; doi: 10.1016/j.atherosclerosis.2008.08.016
7. Himmelfarb J., Stenvinkel P., Ikizler T.A., and Hakim R.M. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 62 (2002) 1524-1538
8. Locatelli F., Canaud B., Eckardt K.-U., Stenvinkel P., Wanner C., and Zoccali C. Oxidative stress in end stage renal: an emerging threat to patient outcome. Nephrol Dial Transplant 18 (2003) 1272-1280
9. Fernández Vega F., Marín Iranzo R., and Herrero P. Comorbilidad vascular en la insuficiencia renal. Nefrología 25 Supl 4 (2005) 72-77
10. Sarnak M.J., Levey A.S., Schoolwerth A.C., Coresh J., Culleton B., Hamm L.L., et al. Kidney disease as a risk factor for development of cardiovascular disease. A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108 (2003) 2154-2169
11. Go A.S., Chertow G.M., Fan D., McCulloch C.E., and Hsu C. Chronic kidney disease and the risk of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004) 1296-1305
12. Gerstein H.C., Mann J.F., Yi Q., et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286 (2001) 421-426
13. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. National Heart, Lung and Blood Institute Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-72.
14. National Kidney Foundation K/DOQI clinical practice guidelines on managing dyslipidemias in chronic kidney disease. Am J Kidney Dis 41 Suppl 3 (2003) S1-S77
15. Danziger R.S., Tobin J.D., Becker L.C., et al. The age associated decline in glomerular filtration in healthy normotensive volunteers. Lack of relationship to cardiovascular performance. J Am Geriatr Soc 38 (1990) 1127-1132
16. Lindeman R.D., Tobin J., and Shock N.W. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 33 (1985) 278-285
17. Epstein M. Aging and the kidney. J Am Soc Nephrol 7 (1996) 1106-1122
18. a ed. (2005), McGraw-Hill, New York 43-53
19. Tedla F., and Friedman E. The trend toward geriatric nephrology. Prim Care Clin Office Pract 35 (2008) 515-530
20. Fletcher A.E., Price G.M., Ng E.S.W., et al. Population based multidimensional assessment of older people in UK general practice: cluster randomised factorial trial. Lancet 364 (2004) 1667-1677
21. Coresh J., Selvin E., Stevens L., et al. Prevalence of chronic kidney disease in the United States. JAMA 298 (2007) 2038-2047
22. Roderick P., Atkins R., Smeeth L., et al. Detecting chronic kidney disease in older people; what are the implications?. Age Ageing 37 (2008) 179-186
23. Chadban S., Briganti E.M., Kerr P., et al. Prevalence of kidney damage in australian adults: the AusDiab Kidney Study. J Am Soc Nephrol 14 (2003) S131-S138
24. Hallan S.I., Dahl K., Oien C.M., et al. Screening strategies for chronic kidney disease in the general population: follow up of cross sectional health survey. BMJ 333 (2006) 1047-1050
25. Gracia S., Montañés R., Jover J., et al. Documento de consenso: recomendaciones sobre la utilización de ecuaciones para la estimación del filtrado glomerular en adultos. Nefrología 26 (2006) 658-665
26. Marín R., Fernández-Vega F., Gorostidi M., et al. Blood pressure control in patients with chronic renal insufficiency in Spain: a cross sectional study. J Hypertens 24 (2006) 395-402
27. Alcázar R., Egocheaga M., Orte L., et al. Documento de consenso SEM-semFYC sobre la enfermedad renal crónica. Nefrologia 28 (2008) 273-282
28. Brown W.W., Peters R.M., Ohmit S.E., et al. Early detection of kidney disease incommunity settings: The Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 42 (2003) 22-35
29. John R., Webb M., Young A., et al. Unreferred chronic kidney disease: a longitudinal study. Am J Kidney Dis 43 (2004) 825-835
30. Eriksen B.O., and Ingebretsen O.C. The progression of chronic kidney disease: a 10 year population based study of the effects of gender and age. Kidney Int 69 (2006) 375-382
31. Marín Iranzo R., Fernández-Vega F., Díez Ojea B., et al. Marcadores de progresión de enfermedad renal crónica en pacientes con nefrosclerosis. Datos evolutivos. Estudio PRONEFROS [resumen]. Nefrología 28 (2008) 48
32. O'Hare A.M., Choi A.I., Bertenthal D., et al. Age affects poutcomes in chronic kidney disease. J Am Soc Nephrol 18 (2007) 2758-2765
33. Raymond N.T., Zehnder D., Smith S.C.H., et al. Elevated relative mortality risk with mild to moderate chronic kidney disease decreases with age. Nephrol Dial Transplant 22 (2007) 3214-3220
34. Glassock R., and Winearls C. An epidemia of chronic kidney disease: fact or fi ction?. Nephrol Dial Transplant 23 (2008) 1117-1121
35. Wetzels J.F.M., Kiemeney L.A.L.M., Swinkels D.W., et al. Age-and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study. Kidney Int 72 (2007) 632-637
36. Steinman M.A., Borzecki A., and Walter L.C. Mortality risk stratification inchronic kidney disease: one size for all ages?. J Am Soc Nephrol 17 (2006) 846-853
37. Ma Y.C., Zuo L., Chen J.H., et al. Modified glomerular filtration rate estimating equations for Chinese patients with chronic kidney disease. J Am Soc Nephrol 17 (2006) 2937-2944
38. Stengel B., Loury P., Froissart M., et al. Long-term outcome in the elderly with chronic kidney disease (CKD) in the general population (Abstract). Nephrol Dial Transplant 22 Suppl 6 (2007) vi226
39. Coresh J., Stevens L.A., and Levey A.S. Chronic kidney disease is common: what do we do next?. Nephrol Dial Transplant 23 (2007) 1122-1125
40. Stevens L.A., Coresh J., and Levey A.S. CKD in the elderly. Old questions and new challenges: World Kidney Day 2008. Am J Kidney Dis 51 (2008) 353-357
41. Shlipak M.G., Katz R., Sarnak M.J., Fried L.F., Newman A.B., Stehman-Breen C., et al. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med 145 (2006) 237-246
42. De Jong P.E., Van der Velde M., Gansevoort R.T., et al. Screening for chronic kidney disease: where does Europe go?. Clin J Am Soc Nephrol 3 (2008) 616-623